HEALTH TECHNOLOGY ASSESSMENT AND ENVIRONMENTAL COSTS- TIME FOR HEALTH CARE TO CATCH UP?

Author(s)

Marsh K1, Ganz M2, Hsu J3, Strandberg-Larsen M4, Palomino Gonzalez R4, Lund N4
1Evidera, London, UK, 2Evidera, Lexington, MA, USA, 3Harvard Medical School, Boston, MA, USA, 4Novo Nordisk A/S, Bagsværd, Denmark

Objectives. The United Nations recently published its most definitive report, calling for greater action on climate change. Historically, however, health technology assessment (HTA) has had a more narrow focus with emphasis on the health of patients and health inequalities. Recently some healthcare decision makers have extended the focus to include the environment, e.g. the Swedish Government is considering a Green Premium for generic drugs, and the UK NHS has CO2 emissions targets. We consider the case for incorporating environmental impacts into HTA, and the associated methodological challenges. Methods. We reviewed healthcare decisions where environmental impacts were considered - a summary will be provided in the paper. We then convened a workshop with key opinion leaders. Results. There are two lines of reasoning for incorporating environmental impacts into HTA: 1) Direct impact: changes in the environment could affect the health of individuals; and 2) Health decision makers’ objectives are broader and are informed by other policy goals, such as the CO2 targets adopted by the NHS in the UK. We also identified two types of methodological challenges for implementation. First, the nascent evidence base is insufficient to support the accurate comparison of the environmental impact of technologies.  Second, uncertainty about how best to incorporate evidence into HTA. The cost-utility analysis approach favoured by many HTA agencies could capture some of the value of environmental impacts – in particular, those that generate health impacts. Both cost-benefit analysis and multi-criteria decision analysis have potential, having both previously been applied to evaluate both health and environmental interventions, though are less familiar to health care decision makers. Conclusion Further work is needed to track decision makers’ demand for evidence on environmental impacts. Robust methods also are needed for capturing and incorporating environmental data as part of HTA as more decision makers begin incorporating environmental impacts.

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PRM245

Topic

Methodological & Statistical Research

Topic Subcategory

Confounding, Selection Bias Correction, Causal Inference

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×